Disturbance of proteasomal and autophagic protein degradation pathways by amyotrophic lateral sclerosis-linked mutations in ubiquilin 2
Abstract
Ubiquilin (UBQLN), a member of the ubiquitin-like (UBL)-ubiquitin-associated (UBA) family, is a dual regulator of both the proteasomal and autophagic branches of the cellular protein degradation system. Mutations in the UBQLN2 gene encoding ubiquilin 2 cause X-linked amyotrophic lateral sclerosis (ALS)/frontotemporal dementia (FTD), and UBQLN2-positive inclusions have been identified in ALS patients with UBQLN2 mutations as well as in cases of both familial and sporadic ALS without UBQLN2 mutations. Compelling evidence links UBQLN2 to disturbance of the protein quality control network in neurons, but the pathomechanisms remain obscure. This study aimed to clarify how ALS-linked mutations in UBQLN2 affect the protein degradation system. Overexpression of a UBQLN2 with ALS-associated mutations resulted in the accumulation of polyubiquitinated proteins in neuronal cells, including the ALS-associated protein TDP-43. This effect was dependent on the UBA domain but not on inclusion formation. Immunocytochemistry and protein fractionation analysis of IVm-UBQLN2 cellular distribution indicated that it sequesters ubiquitinated substrates from both the proteasomal and autophagic branches of the protein degradation system, resulting in accumulation of polyubiquitinated substrates. These findings provide a molecular basis for the development of ALS/FTD-associated proteinopathy and establish novel therapeutic targets for ALS.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Overexpression of ALS-linked UBQLN2 mutants interrupts the interaction between UBQLN2 and ATG9-ATG16L1.
“Overexpression of ALS-linked UBQLN2 mutants interrupts the interaction between UBQLN2 and ATG9-ATG16L1 [225]”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [225]
Cites
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936 · see citing works
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409 · see citing works
Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia
Deng, H.-X., Chen, W., Hong, S.-T., Boycott, K. M., Gorrie, G. H., Siddique, N., Yang, Y., Fecto, F., Shi, Y., Zhai, H., et al. (2011) · Nature · doi:10.1038/nature10353 · Cited by 1,174 · see citing works
Enhancement of proteasome activity by a small-molecule inhibitor of USP14
Lee, B., Lee, M. J., Park, S., Oh, D., Elsasser, S., Chen, P., Gartner, C. A., Dimova, N. V., Hanna, J. W., Gygi, S. P., et al. (2010) · Nature · doi:10.1038/nature09299 · Cited by 943 · see citing works
Wong, Y. C., & Holzbaur, E. L. F. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405752111 · Cited by 812 · see citing works
A new subtype of frontotemporal lobar degeneration with FUS pathology
Neumann, M., Rademakers, R., Roeber, S., Baker, M., Kretzschmar, H. A., & Mackenzie, I. R. A. (2009) · Brain · doi:10.1093/brain/awp214 · Cited by 722 · see citing works
Sareen, D., O’Rourke, J. G., Meera, P., Muhammad, A. K. M. G., Grant, S., Simpkinson, M., Bell, S., Carmona, S., Ornelas, L., Sahabian, A., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007529 · Cited by 670 · see citing works
Delivery of ubiquitinated substrates to protein-unfolding machines
Elsasser, S., & Finley, D. J. (2005) · Nature Cell Biology · doi:10.1038/ncb0805-742 · Cited by 364 · see citing works
Zhang, Y., Jansen‐West, K. R., Xu, Y.-F., Gendron, T. F., Bieniek, K. F., Lin, W.-L., Sasaguri, H., Caulfield, T. R., Hubbard, J., Daughrity, L. M., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1336-5 · Cited by 328 · see citing works
Rad23 Promotes the Targeting of Proteolytic Substrates to the Proteasome
Chen, L., & Madura, K. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.13.4902-4913.2002 · Cited by 291 · see citing works
Raasi, S., & Pickart, C. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212841200 · Cited by 250 · see citing works
Mah, A. L., Perry, G. L., Smith, M. A., & Monteiro, M. J. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.4.847 · Cited by 203 · see citing works
Tashiro, Y., Urushitani, M., Inoue, H., Koike, M., Uchiyama, Y., Komatsu, M., Tanaka, K., Yamazaki, M., Abe, M., Misawa, H., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.417600 · Cited by 194 · see citing works
Nuclear transport impairment of amyotrophic lateral sclerosis‐linked mutations in FUS/TLS
Ito, D., Seki, M., Tsunoda, Y., Uchiyama, H., & Suzuki, N. (2010) · Annals of Neurology · doi:10.1002/ana.22246 · Cited by 168 · see citing works
Self-citationUBQLN2/ubiquilin 2 mutation and pathology in familial amyotrophic lateral sclerosis
Williams, K. L., Warraich, S. T., Yang, S., Fifita, J. A., Fernando, R., Rouleau, G. A., Nicholson, G. A., & Blair, I. P. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.05.008 · Cited by 166 · see citing works
Characterization of the dipeptide repeat protein in the molecular pathogenesis of c9FTD/ALS
Yamakawa, M., Ito, D., Honda, T., Kubo, K., Noda, M., Nakajima, K., & Suzuki, N. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu576 · Cited by 145 · see citing works
Self-citationKim, S. H., Shi, Y., Hanson, K. A., Williams, L. M., Sakasai, R., Bowler, M. J., & Tibbetts, R. S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m808064200 · Cited by 117 · see citing works
Synofzik, M., Maetzler, W., Grehl, T., Prudlo, J., Hagen, J. M. V., Haack, T. B., Rebassoo, P., Munz, M., Schöls, L. J., & Biskup, S. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.07.002 · Cited by 105 · see citing works
Integral UBL domain proteins: a family of proteasome interacting proteins
Hartmann‐Petersen, R., & Gordon, C. (2004) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2003.12.006 · Cited by 94 · see citing works
Ayadi, A. E., Stieren, E. S., Barral, J. M., & Boehning, D. F. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206786109 · Cited by 93 · see citing works
Ubiquilin-1 Is a Molecular Chaperone for the Amyloid Precursor Protein*
Stieren, E. S., Ayadi, A. E., Xiao, Y., Siller, E., Landsverk, M., Oberhauser, A., Barral, J., & Boehning, D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.243147 · Cited by 93 · see citing works
Chang, L., & Monteiro, M. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130162 · Cited by 77 · see citing works
Characterization of seipin/BSCL2, a protein associated with spastic paraplegia 17
Ito, D., Fujisawa, T., Iida, H., & Suzuki, N. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.05.004 · Cited by 76 · see citing works
Self-citationDendritic spinopathy in transgenic mice expressing ALS/dementia-linked mutant UBQLN2
Gorrie, G., Fecto, F., Radzicki, D., Weiss, C., Shi, Y., Dong, H., Zhai, H., Fu, R., Liu, E., Li, S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405741111 · Cited by 75 · see citing works
Cassel, J. A., & Reitz, A. B. (2013) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2013.03.020 · Cited by 65 · see citing works
Evidence of a link between ubiquilin 2 and optineurin in amyotrophic lateral sclerosis
Osaka, M., Ito, D., Yagi, T., Nihei, Y., & Suzuki, N. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu575 · Cited by 61 · see citing works
Self-citationCeballos-Diaz, C., Rosario, A. M., Park, H.-J., Chakrabarty, P., Sacino, A., Cruz, P. E., Siemienski, Z., Lara, N., Moran, C., Ravelo, N., et al. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0026-7 · Cited by 58 · see citing works
ALS-linked mutations in ubiquilin-2 or hnRNPA1 reduce interaction between ubiquilin-2 and hnRNPA1
Gilpin, K. M., Chang, L., & Monteiro, M. J. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv020 · Cited by 58 · see citing works
Feng, P., Scott, C. W., Cho, N., Nakamura, H., Chung, Y.-H., Monteiro, M. J., & Jung, J. U. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.9.3938-3948.2004 · Cited by 58 · see citing works
Ubiquilin at a crossroads in protein degradation pathways
Rothenberg, C., & Monteiro, M. J. (2010) · Autophagy · doi:10.4161/auto.6.7.13118 · Cited by 40 · see citing works
Differential recruitment of UBQLN2 to nuclear inclusions in the polyglutamine diseases HD and SCA3
Zeng, L., Wang, B., Merillat, S. A., Minakawa, E. N., Perkins, M., Ramani, B., Tallaksen‐Greene, S. J., Costa, M. D. C., Albin, R. L., & Paulson, H. L. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.06.017 · Cited by 23 · see citing works
Flagged first, then by citations
1 of the 32 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis
Prasad, A., Bharathi, V., Sivalingam, V., Girdhar, A., & Patel, B. K. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00025 · Cited by 770 · see citing works
TDP-43 proteinopathies: a new wave of neurodegenerative diseases
de Boer, E. M. J., Orie, V. K., Williams, T. L., Baker, M. R., Oliveira, H. M. D., Polvikoski, T. M., Silsby, M., Menon, P., van den Bos, M. A. J., Halliday, G. M., et al. (2020) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-322983 · Cited by 373 · see citing works
Dao, T. P., Kolaitis, R.-M., Kim, H.-J., O'Donovan, K., Martyniak, B., Colicino, E., Hehnly, H., Taylor, J. P., & Castañeda, C. A. (2018) · Molecules and Cells · doi:10.1016/j.molcel.2018.02.004 · Cited by 319 · see citing works
Autophagy Receptors and Neurodegenerative Diseases
Deng, Z., Purtell, K., Lachance, V., Wold, M. S., Chen, S., & Yue, Z. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.01.001 · Cited by 239 · see citing works
Autophagy in Neurodegenerative Diseases: A Hunter for Aggregates
Park, H., Kang, J., & Lee, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093369 · Cited by 205 · see citing works
The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight?
Hergesheimer, R. C., Chami, A. A., de Assis, D. R., Vourc’h, P., Andres, C. R., Corcia, P., Lanznaster, D., & Blasco, H. (2019) · Brain · doi:10.1093/brain/awz078 · Cited by 198 · see citing works
Autophagy and ALS: mechanistic insights and therapeutic implications
Chua, J. P., De Calbiac, H., Kabashi, E., & Barmada, S. J. (2022) · Autophagy · doi:10.1080/15548627.2021.1926656 · Cited by 189 · see citing works
“of ALS-linked UBQLN2 mutants interrupts the interaction between UBQLN2 and ATG9-ATG16L1 [225], while also”
BackgroundTDP-43 post-translational modifications in health and disease
Buratti, E. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1439923 · Cited by 188 · see citing works
Distinct proteostasis circuits cooperate in nuclear and cytoplasmic protein quality control
Samant, R. S., Livingston, C. M., Sontag, E. M., & Frydman, J. (2018) · Nature · doi:10.1038/s41586-018-0678-x · Cited by 169 · see citing works
Autophagy Dysregulation in ALS: When Protein Aggregates Get Out of Hand
Ramesh, N., & Pandey, U. B. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00263 · Cited by 150 · see citing works
Key role of UBQLN2 in pathogenesis of amyotrophic lateral sclerosis and frontotemporal dementia
Renaud, L., Picher‐Martel, V., Codron, P., & Julien, J. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0758-7 · Cited by 123 · see citing works
Mitochondria, lysosomes, and dysfunction: their meaning in neurodegeneration
Audano, M., Schneider, A., & Mitro, N. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14471 · Cited by 118 · see citing works
Autophagy as a common pathway in amyotrophic lateral sclerosis
Nguyen, D. K. H., Thombre, R., & Wang, J. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.04.006 · Cited by 110 · see citing works
Markovinović, A., Cimbro, R., Ljutić, T., Križ, J., Rogelj, B., & Munitić, I. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.04.005 · Cited by 94 · see citing works
RNA binding proteins and the pathological cascade in ALS/FTD neurodegeneration
Ito, D., Hatano, M., & Suzuki, N. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aah5436 · Cited by 92 · see citing works
Self-citationLe, N. T. T., Chang, L., Kovlyagina, I., Georgiou, P., Safren, N., Braunstein, K. E., Kvarta, M. D., Dyke, A. M. V., LeGates, T. A., Philips, T., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1608432113 · Cited by 89 · see citing works
DNA damage as a mechanism of neurodegeneration in ALS and a contributor to astrocyte toxicity
Kok, J. R., Palminha, N. M., Souza, C. D. S., El-Khamisy, S. F., & Ferraiuolo, L. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03872-0 · Cited by 83 · see citing works
TDP-43 pathology: From noxious assembly to therapeutic removal
Keating, S. S., Gil, R. S., Swanson, M. E. V., Scotter, E. L., & Walker, A. K. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102229 · Cited by 74 · see citing works
Phosphorylation-Mediated Clearance of Amyloid-like Assemblies in Meiosis
Carpenter, K., Bell, R. B., Yunus, J., Amon, A., & Berchowitz, L. E. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.04.001 · Cited by 73 · see citing works
Regulation of neuronal autophagy and the implications in neurodegenerative diseases
Cai, Q., & Ganesan, D. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105582 · Cited by 67 · see citing works
Teyssou, E., Chartier, L., Amador, M. D. M., Lam, R., Lautrette, G., Nicol, M., Machat, S., da Barroca, S., Moigneu, C., Mairey, M., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.06.018 · Cited by 67 · see citing works
Is amyotrophic lateral sclerosis/frontotemporal dementia an autophagy disease?
Deng, Z., Sheehan, P., Chen, S., & Yue, Z. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0232-6 · Cited by 61 · see citing works
Recent progress in the role of autophagy in neurological diseases
Meng, T., Lin, S., Zhuang, H., Huang, H., He, Z., Hu, Y., Gong, Q., & Feng, D. (2019) · Cell Stress · doi:10.15698/cst2019.05.186 · Cited by 58 · see citing works
Kalmár, B., & Greensmith, L. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00251 · Cited by 57 · see citing works
Zhang, K., Ailian, W., Zhong, K., Qi, S., Chen, W., Shu, X., Tu, W.-Y., Xu, W., Xia, C., Xiao, Y., et al. (2021) · Neuron · doi:10.1016/j.neuron.2021.04.023 · Cited by 54 · see citing works
Molecular Dissection of TDP-43 as a Leading Cause of ALS/FTLD
Tamaki, Y., & Urushitani, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012508 · Cited by 52 · see citing works
UBQLN proteins in health and disease with a focus on UBQLN2 in ALS/FTD
Lin, B. C., Higgins, N. R., Phung, T. H., & Monteiro, M. J. (2021) · FEBS Journal · doi:10.1111/febs.16129 · Cited by 51 · see citing works
Role of Autophagy Pathway in Parkinson’s Disease and Related Genetic Neurological Disorders
Themistokleous, C., Bagnoli, E., Parulekar, R., & Muqit, M. M. K. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168144 · Cited by 49 · see citing works
Structure, dynamics and functions of UBQLNs: at the crossroads of protein quality control machinery
Zheng, T., Yang, Y., & Castañeda, C. A. (2020) · Biochemical Journal · doi:10.1042/bcj20190497 · Cited by 48 · see citing works
Babazadeh, A., Rayner, S. L., Lee, A., & Chung, R. S. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102085 · Cited by 47 · see citing works
Amyotrophic Lateral Sclerosis: Proteins, Proteostasis, Prions, and Promises
McAlary, L., Chew, Y. L., Lum, J. S., Geraghty, N. J., Yerbury, J. J., & Cashman, N. R. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.581907 · Cited by 45 · see citing works
Argueti-Ostrovsky, S., Alfahel, L., Kahn, J., & Israelson, A. (2021) · Cells · doi:10.3390/cells10092438 · Cited by 45 · see citing works
RNA Binding Proteins and the Pathogenesis of Frontotemporal Lobar Degeneration
Hofmann, J. W., Seeley, W. W., & Huang, E. J. (2018) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012955 · Cited by 42 · see citing works
Exploring the Role of Autophagy Dysfunction in Neurodegenerative Disorders
Rana, T., Behl, T., Sehgal, A., Mehta, V., Singh, S., Bhatia, S., Al‐Harrasi, A., & BUNGAU, S. G. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02472-0 · Cited by 41 · see citing works
Walker, C., & El‐Khamisy, S. F. (2018) · Brain · doi:10.1093/brain/awy076 · Cited by 39 · see citing works
Autophagy-related proteins: Potential diagnostic and prognostic biomarkers of aging-related diseases
Miceli, C., Leri, M., Stefani, M., & Bucciantini, M. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101967 · Cited by 39 · see citing works
Gadhave, K., Kumar, P., Kapuganti, S. K., Uversky, V. N., & Giri, R. (2020) · Biomolecules · doi:10.3390/biom10050796 · Cited by 36 · see citing works
Cheney, L., Guzik, H. M., Macaluso, F., Macián, F., Cuervo, A. M., & Berman, J. W. (2020) · Cells · doi:10.3390/cells9061426 · Cited by 33 · see citing works
Peng, G., Gu, A., Niu, H., Chen, L., Chen, Y., Zhou, M., Zhang, Y., Liu, J., Cai, L., Liang, D., et al. (2021) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13757 · Cited by 30 · see citing works
Autophagy and lysosomal pathways in nervous system disorders
Bingol, B. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.04.009 · Cited by 31 · see citing works
Picher‐Martel, V., Renaud, L., Bareil, C., & Julien, J. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1411-3 · Cited by 31 · see citing works
Cell death cascade and molecular therapy in ADAR2-deficient motor neurons of ALS
Yamashita, T., & Kwak, S. (2018) · Neuroscience Research · doi:10.1016/j.neures.2018.06.004 · Cited by 28 · see citing works
Jantrapirom, S., Piccolo, L. L., Yoshida, H., & Yamaguchi, M. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.06.017 · Cited by 23 · see citing works
ALS‐linked mutations impair UBQLN2 stress‐induced biomolecular condensate assembly in cells
Riley, J. F., Fioramonti, P. J., Rusnock, A. K., Hehnly, H., & Castañeda, C. A. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15453 · Cited by 21 · see citing works
Mohan, H. M., Trzeciakiewicz, H., Pithadia, A. S., Crowley, E. V., Pacitto, R., Safren, N., Trotter, B., Zhang, C., Zhou, X., Zhang, Y., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04170-z · Cited by 21 · see citing works
RNA Granules and Their Role in Neurodegenerative Diseases
Sidibé, H., & Velde, C. V. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-31434-7_8 · Cited by 20 · see citing works
Seranova, E., Palhegyi, A. M., Verma, S., Dimova, S., Lasry, R., Naama, M., Sun, C., Barrett, T. G., Rosenstock, T. R., Kumar, D., et al. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.01.024 · Cited by 20 · see citing works
Ubiquilin-2 differentially regulates polyglutamine disease proteins
Gerson, J. E., Safren, N., Fischer, S., Patel, R., Crowley, E. V., Welday, J. P., Windle, A. K., Barmada, S. J., Paulson, H. L., & Sharkey, L. M. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa152 · Cited by 19 · see citing works
Complex Analysis of Retroposed Genes’ Contribution to Human Genome, Proteome and Transcriptome
Kubiak, M., Szcześniak, M., & Makałowska, I. (2020) · Genes · doi:10.3390/genes11050542 · Cited by 15 · see citing works
Shah, P. P., Saurabh, K., Kurlawala, Z., Vega, A. A., Siskind, L. J., & Beverly, L. J. (2022) · Neoplasia · doi:10.1016/j.neo.2021.11.010 · Cited by 14 · see citing works
UBQLN2 in neurodegenerative disease: mechanistic insights and emerging therapeutic potential
Matthews, A. M., & Whiteley, A. M. (2025) · Biochemical Society Transactions · doi:10.1042/bst20253053 · Cited by 12 · see citing works
Non-Proteasomal UbL-UbA Family of Proteins in Neurodegeneration
Jantrapirom, S., Piccolo, L. L., & Yamaguchi, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081893 · Cited by 13 · see citing works
UBQLN2 Promotes the Production of Type I Interferon via the TBK1-IRF3 Pathway
Chen, T., Zhang, W., Huang, B., Chen, X., & Huang, C. (2020) · Cells · doi:10.3390/cells9051205 · Cited by 12 · see citing works
Limanaqi, F., Busceti, C. L., Biagioni, F., Cantini, F., Lenzi, P., & Fornai, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114021 · Cited by 11 · see citing works
Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD–associated UBQLN2 mutants
Strohm, L., Hu, Z., Suk, Y., Rühmkorf, A., Sternburg, E. L., Gattringer, V., Riemenschneider, H., Berutti, R., Graf, E., Weishaupt, J. H., et al. (2022) · Life Science Alliance · doi:10.26508/lsa.202101327 · Cited by 11 · see citing works
Regional differences in the inflammatory and heat shock response in glia: implications for ALS
Clarke, B. E., Gil, R. S., Yip, J., Kalmár, B., & Greensmith, L. (2019) · Cell Stress and Chaperones · doi:10.1007/s12192-019-01005-y · Cited by 11 · see citing works
Gu, A., Zhang, Y., He, J., Zhao, M., Ding, L., Liu, W., Xiao, J., Huang, J., Liu, M., & Liu, X. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413448 · Cited by 9 · see citing works
Acetyl-L-carnitine and Amyotrophic Lateral Sclerosis: Current Evidence and Potential use
Marchi, F. D., Venkatesan, S., Saraceno, M., Mazzini, L., & Grossini, E. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230330083757 · Cited by 9 · see citing works
Impaired 26S Proteasome Assembly Precedes Neuronal Loss in Mutant UBQLN2 Rats
Zhang, W., Huang, B., Gao, L., & Huang, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094319 · Cited by 8 · see citing works
Amyotrophic Lateral Sclerosis: Focus on Cytoplasmic Trafficking and Proteostasis
Shrilaxmi, M. S., Banerjee, S., D’Mello, S. R., & Dastidar, S. G. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04831-7 · Cited by 6 · see citing works
Sullivan, P. M., Zhou, X., & Hu, F. (2017) · InTech eBooks · doi:10.5772/intechopen.69371 · Cited by 6 · see citing works
Phung, T. H., Tatman, M., & Monteiro, M. J. (2022) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2022.130284 · Cited by 5 · see citing works
Koopman, M., Güngördü, L., Janssen, L., Seinstra, R. I., Richmond, J. E., Okerlund, N. D., Wardenaar, R., Islam, P., Hogewerf, W., Brown, A. E., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114204 · Cited by 5 · see citing works
Navigating the Autophagy Maze: ATG and Their Impact on Neurodegenerative Diseases
Amirian, R., Merati, A., Babamohamadi, M., Mirahmadi, Y., Esfahani, M. L., Rahmani, S., Izadi, Z., & Rezazadeh, D. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05332-3 · Cited by 4 · see citing works
Targets and Gene Therapy of ALS (Part 1)
Shiryaeva, O. A., Tolochko, C., Alekseeva, T. M., & Dyachuk, V. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094063 · Cited by 3 · see citing works
Nishanth, D. S., Sinha, U., Verma, T., Kalidass, B., Thirumuruganandham, S. P., & Muthukaliannan, G. K. (2026) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01659-6 · Cited by 2 · see citing works
Bauer, J. R., Robinson, T. L., Strich, R., & Cooper, K. (2025) · Cells · doi:10.3390/cells14090636 · Cited by 2 · see citing works
Boosting Brain Clean-Up: Can Targeting UPS Genes Offer Neuroprotection?
Mannan, A., Sharma, A., & Singh, T. G. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05263-z · Cited by 2 · see citing works
Posttranslational modifications of TDP-43
Rahman, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820066-7.20002-7
Drosophila model of amyotrophic lateral sclerosis targeting FUS and ubiquilin
Yamaguchi, M., Jantrapirom, S., Piccolo, L. L., Ida, H., & Yoshida, H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89833-1.00033-1
Koopman, M., Güngördü, L., Janssen, L., Seinstra, R. I., Richmond, J. E., Okerlund, N. D., Wardenaar, R., Islam, P., Brown, A. E., Jørgensen, E. M., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.24.563563
UBQLN2 facilitates degradation of the retrotransposon protein PEG10 via UBE3A activityPreprint
Roberts, J. E., Huynh, P. T., & Whiteley, A. M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.28.646022
de Calbiac, H. (2019) · theses.fr (ABES) · doi:10.70675/bafe951fz8332z4b0azb55bzac8a4af1955b
Molecular Dissection of TDP-43 as a Leading Cause of ALS/FTLD
漆谷, 真., Tamaki, Y., & URUSHITANI, M. (n.d.) · Institutional Repositories DataBase (IRDB)
- Authors
- Osaka, M., Ito, D., & Suzuki, N.
- Affiliations
- Keio University (JP)
- Corresponding author
- Ito, Daisuke
- Venue
- Biochemical and Biophysical Research Communications
- Publisher
- Elsevier BV
- Published
- 2016-04
- Volume
- 472
- Issue
- 2
- Pages
- 324-331
- ISSN
- 0006-291X (ISSN-L)
- OpenAlex
- W2289625033
- Cited by
- 75
- References
- 32
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 2 · 2023: 5 · 2022: 7 · 2021: 11 · 2020: 11 · 2019: 8 · 2018: 13 · 2017: 9 · 2016: 1
- FWCI
- 7.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemical and Biophysical Research Communications (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology of Japan (15J05597, 15579156)
- life science foundation of Japan, Brain science foundation
- Japan Amyotrophic Lateral Sclerosis Association
- Topics
- Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Keywords
- UBQLN2, amyotrophic lateral sclerosis, frontotemporal dementia, protein degradation, proteasome, autophagy, UBA domain, polyubiquitinated proteins, TDP-43, protein quality control, neuronal inclusions, therapeutic target
- MeSH terms
- Amyotrophic Lateral Sclerosis, Animals, Autophagy, Cell Line, Mutation, Neurons, Signal Transduction, Proteasome Endopeptidase Complex, Mice, Proteolysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review